4D-710 in Adult Patients With Cystic Fibrosis

Recruiting now · Phase 2

Conditions studied: Cystic Fibrosis Lung

In brief

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.

Key facts

Study ID
NCT05248230
Run by
4D Molecular Therapeutics
People needed
30
Starts
2022-03-29
Expected to finish
2031-06-01
Last updated by the study team
2026-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.